Practice question

Answer the question and get instant feedback.

HardPalliative CareOpioid Conversion/Titrationmrcgp aktukmlapaneprescribing safety assessment

A patient with terminal cancer is taking Modified-Release (MR) Morphine Sulphate 60mg BD (twice daily). They require 4 doses of immediate-release (IR) Morphine Sulphate (Oramorph) 10mg for breakthrough pain in the last 24 hours. What should the new dose of MR Morphine be when reviewed?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.